MedTrace Logo

Intractable Self-harm-What Support is Effective?

NCT06099561 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2026-04-29

No results posted yet for this study

Summary

The aim of this project is to evaluate a novel treatment program for individuals with intractable and lethal self-harm.

The main questions are:

1: Is there, in individuals with intractable self-harm, a relevant improvement in daily functioning and is this improvement related to the provided interventions?

The secondary research questions are:

2\. Is there, in individuals with intractable self-harm, a relevant improvement in frequency and severity of self-harm?

3\. Is there, in individuals with intractable self-harm, a relevant improvement in voluntary hospital admissions?

4\. Is there, in individuals with intractable self-harm, a relevant improvement in compulsary hospital admissions?

5\. Is there, in individuals with intractable self-harm, a relevant improvement in the use of medication pro re nata?

6\. Is there, in individuals with intractable self-harm, a relevant improvement in cost-effectiveness related to the provided interventions?

Conditions

Interventions

BEHAVIORAL

National specialized medical care unit for severe self-harm behaviour-Consultation model

Extensive assessments. Consultation and training for existing treatment providers and caregivers. Network-meetings for providers and caregivers.

Sponsors & Collaborators

  • Department of Psychology. Lund University.

    collaborator UNKNOWN

  • Department of Clinical Sciences, Malmö. Faculty of Medicine, Lund University.

    collaborator UNKNOWN

  • Region Skane

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-01
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06099561 on ClinicalTrials.gov